Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00765128 · ClinicalTrials.gov registry record · Phase 4
Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT00765128: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT00765128 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00765128, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having percutaneous nephrolithotomy for kidney stone disease.
Interventions
- DRUG Placebo
- DRUG Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00765128
The ClinicalTrials.gov registry entry for NCT00765128 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00765128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00765128 about?
NCT00765128 is a clinical study titled "Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy". The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having percutaneous nephrolithotomy for kidney stone disease.
What is the current status of trial NCT00765128?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2008-10. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00765128?
The interventions under investigation include: Placebo (DRUG), Ketorolac (DRUG).
Who is sponsoring clinical trial NCT00765128?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.